| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3204208 | The Journal of Allergy and Clinical Immunology: In Practice | 2014 | 7 Pages |
Abstract
Risks of asthma-related exacerbations did not differ between children who initiated LTRA and ICS. These findings may be explainable by LTRA, which has similar effectiveness as ICS in real-life usage by residual confounding by indication or other unmeasured factors.
Keywords
Kaiser Permanente NorthwestHDPsHPHCKPNCLTRAKPNWICSPDCKaiser Permanente Northern CaliforniaAsthmaleukotriene antagonistLong-acting β-agonistLong-acting β2-agonistEffectivenessemergency departmentcontroller medicationsLABAhazard ratioproportion of days coveredInhaled corticosteroidInhaled corticosteroids
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Ann Chen MD, MPH, Lingling PhD, Vicki PhD, Elyse O. MD, MPH, Emma K. PhD, William M. PhD, Melissa G. PharmD, MPH, PhD, Irina MS, Donna BA, Robert L. MD, MPH, Tina MD, MPH, Scott T. MD, MS, Tracy A. MD, MPH,